Form 8-K - Current report:
SEC Accession No. 0000950170-22-027082
Filing Date
2022-12-29
Accepted
2022-12-29 09:10:31
Documents
14
Period of Report
2022-12-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20221229.htm   iXBRL 8-K 63897
2 EX-99.1 hrtx-ex99_1.htm EX-99.1 29860
3 GRAPHIC img253235095_0.jpg GRAPHIC 56635
  Complete submission text file 0000950170-22-027082.txt   301709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrtx-20221229_lab.xml EX-101.LAB 17754
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrtx-20221229_pre.xml EX-101.PRE 11060
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrtx-20221229.xsd EX-101.SCH 2471
8 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20221229_htm.xml XML 4716
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 221496439
SIC: 2834 Pharmaceutical Preparations